| Vol. 13,49 – 14 December, 2021 |
| |
|
|
| The development of a bioactive nanocomplex formed along with polydeoxyribonucleotide and bone morphogenetic protein 2 (BMP2) provided synergistic abilities in angiogenesis and bone regeneration. [Science Advances] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Investigators found that Trio was highly expressed in osteosarcoma than normal tissues and promoted the proliferation, migration, and invasion of osteosarcoma cells. [Cell Death & Disease] |
|
|
|
| The authors analyzed the gene expression and outcome of 980 sarcoma patients from seven public datasets. The abundance of immune cells and the response to immunotherapy was calculated. [Molecular Therapy-Oncolytics] |
|
|
|
| Investigators showed that compared with MSC-exosomes (exos) generated via 2D culture, 3D-exos showed enhanced anti-inflammatory effects in a ligature-induced model of periodontitis by restoring the reactive T helper 17 cell/Treg balance in inflamed periodontal tissues. [International Journal of Oral Science] |
|
|
|
| Exosomes were extracted from the supernatant of the bone-marrow MSCs. The expression of the micro-RNA miR-93-3p was determined by qRT-PCR analysis. [Bioengineered] |
| |
|
|
| Researchers indicated that KLF4 played opposing roles in platelet-derived growth factor receptor-β+ cells and α-smooth muscle actin+ cells and highlighted the importance of further studies of interactions between distinct mesenchymal cell types. [Nature Communications] |
|
|
|
| Using unbiased transcriptome profiling of hypoxia-preconditioned MSCs and normoxic MSCs, scientists identified a lncRNA named lung cancer-associated transcript 1 (LUCAT1) under hypoxia. [Molecular Therapy-Nucleic Acids] |
|
|
|
| Researchers reported a facile and efficient strategy for in vivo tracking the secretion of hepatocyte growth factor in MSCs during idiopathic pulmonary fibrosis therapy. [Biomaterials Science] |
|
|
|
| A type 2 diabetes mellitus (T2DM) model was established through 28-week high-fat diet feeding resulting in T2DM-associated non-alcoholic fatty liver disease, followed by the injection of bone marrow MSCs. [Stem Cell Research & Therapy] |
|
|
|
| Investigators manufactured neprilysin gene-enhanced human umbilical cord-derived MSCs and intravenously transplanted them in Aβ1-42-injected Alzheimer’s disease animal models. [Stem Cells International] |
|
|
|
| The authors reported the use of MSCs for the production and delivery of Gastrin, a peptide hormone that is produced by intestinal cells and fetal islets and can increase β-cell mass, to promote protection from type 1 diabetes. [Autoimmunity] |
|
|
|
|
| Scientists review MSC-based nanocomposite’s current approaches and compared their advantages and limitations for building effective regenerative medicines. [European Journal of Pharmacology] |
|
|
|
| Investigators review the potential application of MSC extracellular vesicles as an emerging treatment strategy for optic neuritis by reviewing studies in multiple sclerosis and related disorders. [Current Stem Cell Research & Therapy] |
|
|
|
|
| Sanford Health announced a stem cell trial expanding the use of adult-adipose derived stem cells in the use of osteoarthritis across five joints. The clinical trial, called the ENDURE trial, is the first of its kind study. [Stanford Health] |
|
|
|
|
| February 6 – 9, 2022 Keystone Resort, Colorado, United States |
|
|
|
|
|
| Ecole polytechnique fédérale de Lausanne – Lausanne, Canton of Vaud |
|
|
|
| Karolinska Institute – Solna, Sweden |
|
|
|
| Centre de recherche du CHUM – Montreal, Quebec, Canada |
|
|
|
| Stanford University – Palo Alto, California, United States |
|
|
|
| University of Calgary – Calgary, Alberta, Canada |
|
|
|
|